🚨 ASTRAZENECA ANNOUNCES US$2 BILLION INVESTMENT AstraZeneca said on Tuesday it will make a US$2 billion equity investment in Florida-headquartered Summit Therapeutics. Summit Therapeutics holds the exclusive rights to develop and commercialise Akeso’s immunotherapy drug ivonescimab outside China. Source: South China Morning Post #AstraZeneca #Merck
